H.C. Wainwright Gives NeuroPace (NPCE) a Boost with Strong Buy Recommendation

On May 28, H.C. Wainwright analyst Yi Chen started covering NeuroPace, Inc. (NASDAQ: NPCE It has been assigned a Buy rating along with a price target set at $18. This recommendation follows the release of initial findings from the one-year data in the NAUTILUS study.

On May 27, the firm disclosed pivotal outcomes from the NAUTILUS study, which was the initial clinical investigation assessing its RNS system for treating medication-refractory idiopathic generalized epilepsy. After three months following implantation, the study achieved its main safety objective, showcasing a minimal incidence of severe side effects and supporting the pre-established safe track record of the device. According to an analysis, during the clinical phase, the system showed substantial decreases in seizures.

A detailed view of a medical instrument being adjusted and checked within a clinic lab environment.

Furthermore, NeuroPace, Inc. (NASDAQ:NPCE) reported strong performance for the first quarter of fiscal 2025. Revenue increased by over 24%, reaching $22.52 million, which was above projections by $676,490. Additionally, the earnings per share came in at -$0.21, beating estimates by $0.03. Analysts noted that the stock price has risen more than 150% within the last year, and recent findings from their studies indicate a compelling opportunity for potential investment.

NeuroPace Inc., listed as NPCE on NASDAQ, operates as a commercial-stage medical equipment firm specializing in the creation of the RNS system. This particular apparatus is an implanted neurological device engineered to lessen or stop seizure occurrences in individuals suffering from medication-resistant epilepsy.

Although we recognize the appeal of NPCE as a possible investment, we feel that certain AI stocks offer stronger prospects for providing substantial gains with reduced risk. Should you be seeking an AI stock that surpasses NPCE in terms of growth potential and boasts up to 100 times the upside opportunity, consider reviewing our detailed report on this subject. cheapest AI stock .

READ NEXT: 11 Up-and-Coming Tech Stocks That Analysts Are Bullish On and 12 Top Growth Stocks to Purchase and Keep for the Long Haul .

Disclosure: None.